Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular r...
Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus
About this item
Full title
Author / Creator
Kohlmorgen, Christina , Gerfer, Stephen , Feldmann, Kathrin , Twarock, Sören , Hartwig, Sonja , Lehr, Stefan , Klier, Meike , Krüger, Irena , Helten, Carolin , Keul, Petra , Kahl, Sabine , Polzin, Amin , Elvers, Margitta , Flögel, Ulrich , Kelm, Malte , Levkau, Bodo , Roden, Michael , Fischer, Jens W. and Grandoch, Maria
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Aims/hypothesis
People with diabetes have an increased cardiovascular risk with an accelerated development of atherosclerosis and an elevated mortality rate after myocardial infarction. Therefore, cardioprotective effects of glucose-lowering therapies are of major importance for the pharmacotherapy of individuals with type 2 diabetes. For sodium...
Alternative Titles
Full title
Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8245397
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8245397
Other Identifiers
ISSN
0012-186X
E-ISSN
1432-0428
DOI
10.1007/s00125-021-05498-0
